Centiva Capital, LP Staar Surgical CO Transaction History

Centiva Capital, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$30.6 - $43.78 $614,142 - $878,664	20,070 New	20,070 $626,000
Q3 2022 Nov 14, 2022	BUY	$70.55 - $111.58 $328,551 - $519,628	4,657 New	4,657 $329,000
Q3 2021 Nov 15, 2021	SELL	$122.75 - $162.68 $227,087 - $300,958	-1,850 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$105.76 - $154.96 $1.17 Million - $1.71 Million	-11,054 Reduced 85.66%	1,850 $282,000
Q1 2021 May 17, 2021	BUY	$78.5 - $126.48 $490,782 - $790,752	6,252 Added 93.99%	12,904 $1.36 Million
Q4 2020 Feb 16, 2021	BUY	$55.93 - $82.78 $372,046 - $550,652	6,652 New	6,652 $527,000
Q3 2020 Nov 16, 2020	SELL	$45.65 - $61.81 $375,653 - $508,634	-8,229 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$29.15 - $61.54 $239,875 - $506,412	8,229 New	8,229 $506,000

251

47.3M

427K

206K

Ticker STAA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 48,038,300
Market Cap $1.15B
Description
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Centiva Capital, LP with notifications on news.